A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL
about
A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@ast
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@en
type
label
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@ast
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@en
prefLabel
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@ast
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@en
P2093
P2860
P356
P1433
P1476
A CD21 low phenotype, with no ...... t with a poor prognosis in CLL
@en
P2093
Chris Fegan
Chris J Pepper
Eva-Maria Nichols
Rachael Watson
Rachel Jones
P2860
P304
32669-32680
P356
10.18632/ONCOTARGET.5404
P407
P577
2015-10-03T00:00:00Z